Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) is a gut peptide that, together with its receptor, GLP-1R, is expressed in the brain. Here we show that intracerebroventricular (i.c.v.) GLP-1 and [Ser(2)]exendin(1-9) (HSEGTFTSD; homologous to a conserved domain in the glucagon/GLP-1 family) enhance associative and spatial learning through GLP-1R. [Ser(2)]exendin(1-9), but not GLP-1, is also active when administered peripherally. GLP-1R-deficient mice have a phenotype characterized by a learning deficit that is restored after hippocampal Glp1r gene transfer. In addition, rats overexpressing GLP-1R in the hippocampus show improved learning and memory. GLP-1R-deficient mice also have enhanced seizure severity and neuronal injury after kainate administration, with an intermediate phenotype in heterozygotes and phenotypic correction after Glp1r gene transfer in hippocampal somatic cells. Systemic administration of [Ser(2)]exendin(1-9) in wild-type animals prevents kainate-induced apoptosis of hippocampal neurons. Brain GLP-1R represents a promising new target for both cognitive-enhancing and neuroprotective agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1 is involved in cognitive brain function and learning, 98”
From GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits (2026) · cites this paper as [98]
In the citing paper
“GLP1-RAs is known for its neuroprotective action, and more recent results have emerged, showing a potential benefit in people with AD [85,86,87].”
From Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies (2023) · cites this paper as [86]
In the citing paper
“They are involved in multiple biological pathways that could be beneficial in AD including improvement of BBB integrity and vascular health, promotion of homeostasis in microglia and astrocytes, positive effects on adaptative immune cells (including natural killer cells and activated regulatory T cells), improvement of synaptic viability, and neuroprotection [17–26].”
In the citing paper
“Preclinical results in murine models treated with GLP-1RAs suggest that the potential effects of semaglutide in AD may be exerted via impact on several AD-related pathophysiologic processes including neuroinflammatory pathways, vascular and BBB integrity, reduced synaptic loss, and neuroprotection [19, 21, 23–26, 46–48];”
Citations
Cites
Modification of seizure activity by electrical stimulation: II. Motor seizure
Racine, R. J. (1972) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(72)90177-0 · Cited by 7,171
Place navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Sniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356
Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration
Schmued, L. C., & Hopkins, K. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02513-0 · Cited by 1,218 · cited 1×
“Immunohistochemical comparison of the CA3 subregion of the hippocampus using Fluorojade-B, a fluorochrome stain specific for degenerating neuron”
MethodKieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
Self-citationEnvironmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
Young, D., Lawlor, P. A., Leone, P., Dragunow, M., & During, M. J. (1999) · Nature Medicine · doi:10.1038/7449 · Cited by 732
Self-citationStoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., & Egan, J. M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.741 · Cited by 576
Self-citation
Cited by
Items 201–300 of 859
Rachmany, L., Tweedie, D., Li, Y., Rubovitch, V., Holloway, H. W., Miller, J. P., Hoffer, B. J., Greig, N. H., & Pick, C. G. (2012) · AGE · doi:10.1007/s11357-012-9464-0 · Cited by 96
Hölscher, C. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140016 · Cited by 96
Exendin-4 decreases amphetamine-induced locomotor activity
Erreger, K., Davis, A. R., Poe, A. M., Greig, N. H., Stanwood, G. D., & Galli, A. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.014 · Cited by 95
Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
Buccellato, F. R., D’Anca, M., Tartaglia, G. M., Del Fabbro, M., Scarpini, E., & Galimberti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813900 · Cited by 94
Hölscher, C., & Li, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.023 · Cited by 100
Calsolaro, V., & Edison, P. (2015) · CNS Drugs · doi:10.1007/s40263-015-0301-8 · Cited by 93
Gault, V. A., Porter, W. D., Flatt, P. R., & Hölscher, C. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.59 · Cited by 99
The gut hormone glucagon-like peptide-1 produced in brain: is this physiologically relevant?
Trapp, S., & Richards, J. E. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.006 · Cited by 92
Harasta, A. E., Power, J., von Jonquières, G., Karl, T., Drucker, D. J., Housley, G. D., Schneider, M., & Klugmann, M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.47 · Cited by 97
Self-citationGlucagon like peptide-1 (GLP-1) likes Alzheimer’s disease
Simsir, I. Y., Soyaltın, U. E., & Çetinkalp, Ş. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.002 · Cited by 96
Sebastião, I., Candeias, E., Santos, M. S., de Oliveira, C. R., Moreira, P. I., & Duarte, A. I. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00110 · Cited by 92
The Metabolic Syndrome and Aging
Morley, J. E. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.2.m139 · Cited by 92
Hayes, M. R., Mietlicki-Baase, E. G., Kanoski, S. E., & De Jonghe, B. C. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161201 · Cited by 92
Growth hormone (GH) and brain trauma
Devesa, J., Reimunde, P., Devesa, P., Barberá, M., & Arce, V. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.022 · Cited by 87
Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke
Ling, Y., Gong, T., Zhang, J., Gu, Q., Gao, X., Weng, X., Liu, J., & Sun, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.511562 · Cited by 101
The impact of dietary energy intake on cognitive aging
Mattson (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.005.2010 · Cited by 91
Liu, H., Chen, Y., Li, F., & Zhang, H. (2012) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2012.723203 · Cited by 96
Wiciński, M., Socha, M., Malinowski, B., Wódkiewicz, E., Walczak, M., Górski, K., Słupski, M., & Pawlak-Osińska, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051050 · Cited by 89
Grotemeyer, A., McFleder, R. L., Wu, J., Wischhusen, J., & Ip, C. W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878771 · Cited by 90
Xu, W., Yang, Y., Yuan, G., Zhu, W., Ma, D., & Hu, S. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000129 · Cited by 89
The microbiota-gut-brain axis: Focus on the fundamental communication pathways
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 88
Ammar, R. A., Mohamed, A. F., Kamal, M. M., Safar, M. M., & Abdelkader, N. F. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00956-6 · Cited by 84
Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
Estall, J., & Drucker, D. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873671 · Cited by 88
Self-citationShi, T., Shen, S., Shi, Y., Wang, Q., Zhang, G., Lin, J., Chen, J., Bai, F., Zhang, L., Wang, Y., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00989-x · Cited by 87
Wu, H.-Y., Tang, X.-Q., Mao, X.-F., & Wang, Y.-X. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1799-17.2017 · Cited by 87
de Souza, A. G., Chaves Filho, A. J. M., Souza Oliveira, J. V., de Souza, D. A. A., Lopes, I. S., de Carvalho, M. A. J., de Lima, K. A., Florenço Sousa, F. C., Mendes Vasconcelos, S. M., Macedo, D., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.066 · Cited by 87
Zhou, M., Chen, S., Peng, P., Gu, Z., Yu, J., Zhao, G., & Deng, Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.103 · Cited by 85
Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential
Sinclair, E. M., & Drucker, D. J. (2005) · Physiology · doi:10.1152/physiol.00030.2005 · Cited by 87
Self-citationDrug development for Alzheimer’s disease: Review
Lao, K., Ji, N., Zhang, X., Qiao, W., Tang, Z., & Gou, X. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2018.1474361 · Cited by 86
“[97] During MJ, Cao L, Zuzga DS, et al.”
BackgroundNeurotrophic Property of Geniposide for Inducing the Neuronal Differentiation of PC12 Cells
Liu, J., Zheng, X., Yin, F., Hu, Y., Guo, L., Deng, X., Chen, G., Jiajia, J., & Zhang, H. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2006.08.009 · Cited by 86
Liu, W. J., Jin, H. Y., Lee, K. A., Xie, S. H., Baek, H. S., & Park, T. S. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01272.x · Cited by 84
Pabreja, K., Mohd, M. A., Koole, C., Wootten, D., & Furness, S. G. B. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12313 · Cited by 84
Bomba, M., Ciavardelli, D., Silvestri, E., Canzoniero, L. M., Lattanzio, R., Chiappini, P., Piantelli, M., Di Ilio, C., Consoli, A., & Sensi, S. L. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.139 · Cited by 84
Jin, H. Y., Liu, W. J., Park, J. H., Baek, H. S., & Park, T. S. (2009) · Archives of Medical Research · doi:10.1016/j.arcmed.2009.09.005 · Cited by 94
Intravitreal Injection of Exendin-4 Analogue Protects Retinal Cells in Early Diabetic Rats
Zhang, Y., Zhang, J., Wang, Q., Lei, X., Chu, Q., Xu, G.-T., & Ye, W. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4727 · Cited by 84
Lovshin, J. A., Huang, Q., Seaberg, R., Brubaker, P. L., & Drucker, D. J. (2004) · Endocrinology · doi:10.1210/en.2004-0100 · Cited by 84
Self-citationGlucagon-Like Peptide-1-Based Therapies for the Treatment of Type 2 Diabetes Mellitus
Gallwitz, B. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504060-00005 · Cited by 93
Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide
Candeias, E. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.807 · Cited by 83
Gonçalves, A., Marques, C., Leal, E. C., Ribeiro, C., Reis, F., Ambrósio, A. F., & Fernandes, R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.013 · Cited by 91
Neuroinflammation in Parkinson"s Disease and its Treatment Opportunities
Çınar, E., Tel, B. C., & Şahin, G. (2022) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2022.2022-7-100 · Cited by 97
Modulation of Hippocampal Neural Plasticity by Glucose-Related Signaling
Mainardi, M., Fusco, S., & Grassi, C. (2015) · Neural Plasticity · doi:10.1155/2015/657928 · Cited by 81
Hölscher, C. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.181 · Cited by 82
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
Thulasinathan, B., Suvilesh, K. N., Maram, S., Grossmann, E. M., Ghouri, Y. A., Teixeiro, E., Chan, J., Kaifi, J. T., & Rachagani, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2483780 · Cited by 93
El-Sahar, A. E., Safar, M. M., Zaki, H. F., Attia, A. S., & Ain-Shoka, A. A. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.01.030 · Cited by 84
Guo, B., Zhang, J., Zhang, W., Chen, F., & Liu, B. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2272769 · Cited by 96
Glucagon-Like Peptide 1, Insulin, Sensory Neurons, and Diabetic Neuropathy
Kan, M., Guo, G., Singh, B., Singh, V., & Zochodne, D. W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182580673 · Cited by 80
Type 2 Diabetes and Cognitive Impairment: Contributions From Neuroimaging
Ryan, J. P., Fine, D. F., & Rosano, C. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516543 · Cited by 80
Katagiri, D., Hamasaki, Y., Doi, K., Okamoto, K., Negishi, K., Nangaku, M., & Noiri, E. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020134 · Cited by 80
Egefjord, L., Gejl, M., Møller, A., Brændgaard, H., Gottrup, H., Antropova, O., Møller, N., Poulsen, H. E., GJEDDE, A. H., Brock, B., et al. (2012) · PubMed · Cited by 91
Detka, J., & Głombik, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00274-8 · Cited by 79
“It is noteworthy that a behavioral analysis of Glp1r +/+ , Glp1r +/− and Glp1r−/− mouse phenotypes and hippocampal Glp1r gene transfer demonstrated that deficiency of this receptor results in decrements in the acquisition of associative contextual learning which can be improved by hippocampal Glp1r somatic cell gene t…”
BackgroundRole of the blood–brain barrier in the evolution of feeding and cognition
Banks, W. A. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06568.x · Cited by 79
Self-citationBae, C., & Song, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112493 · Cited by 77
Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?
Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 83
Nizari, S., Basalay, M., Chapman, P., Korte, N., Korsak, A., Christie, I. N., Theparambil, S. M., Davidson, S. M., Reimann, F., Trapp, S., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00873-9 · Cited by 77
“However, the mechanisms underlying GLP-1R-mediated neuroprotection remain largely unknown [19, 59].”
BackgroundDipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Joo, K. W., Kim, S., Ahn, S. Y., Chin, H. J., Chae, D., Lee, J., Han, J. S., & Na, K. Y. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-98 · Cited by 82
Batista, A. F., Bodart‐Santos, V., Felice, F. G. D., & Ferreira, S. T. (2018) · CNS Drugs · doi:10.1007/s40263-018-0593-6 · Cited by 77
Li, Q., Jia, M., Yan, Z., Li, Q., Sun, F., He, C., Li, Y., Zhou, X., Zhang, H., Liu, X., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020734 · Cited by 77
Clark, I. A., Atwood, C., Bowen, R. L., Paz-Filho, G., & Vissel, B. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005850 · Cited by 80
Intranasal administration of PACAP: Uptake by brain and regional brain targeting with cyclodextrins
Nonaka, N., Farr, S. A., Nakamachi, T., Morley, J. E., Nakamura, M., Shioda, S., & Banks, W. A. (2012) · Peptides · doi:10.1016/j.peptides.2012.05.021 · Cited by 83
Self-citationKang, H. M., Kim, J.-Y., Park, S., Kim, J., Kim, H., Kim, K. S., Lee, J. E., Seo, S. I., Kang, S. G., Lee, J. E., et al. (2009) · Stem Cells · doi:10.1002/stem.127 · Cited by 74
The Role of GLP-1 in Neuronal Activity and Neurodegeneration
Hölscher, C. (2010) · Vitamins & Hormones · doi:10.1016/b978-0-12-381517-0.00013-8 · Cited by 74
Fang, X., Tian, P., Zhao, X., Jiang, C., & Chen, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14694 · Cited by 72
Chen, S., Zhou, M., Sun, J., Guo, A., Fernando, R. L., Chen, Y., Peng, P., Zhao, G., & Deng, Y. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107668 · Cited by 73
Val‐Laillet, D., Guérin, S., Coquery, N., Nogret, I., Formal, M., Romé, V., Le Normand, L., Meurice, P., Randuineau, G., Guilloteau, P., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700547rr · Cited by 73
Glucagon-like peptide-1 and glucagon-like peptide-2
Baggio, L. L., & Drucker, D. J. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.08.001 · Cited by 84
Self-citationLourenco, M. V., Ferreira, S. T., & Felice, F. G. D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.003 · Cited by 85
Ma, M., Hasegawa, Y., Koibuchi, N., Toyama, K., Uekawa, K., Nakagawa, T., Lin, B., & Kim-Mitsuyama, S. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0218-z · Cited by 72
The incretins: a link between nutrients and well-being
Burcelin, R. (2005) · British Journal of Nutrition · doi:10.1079/bjn20041340 · Cited by 70
New Approaches to Treating Type 2 Diabetes Mellitus in the Elderly: Role of Incretin Therapies
Abbatecola, A. M., Maggi, S., & Paolisso, G. (2008) · Drugs & Aging · doi:10.2165/0002512-200825110-00002 · Cited by 75
Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats
Briyal, S., Gulati, K., & Gulati, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.10.026 · Cited by 71
Neuromodulatory effects of anti-diabetes medications: A mechanistic review
Yaribeygi, H., Ashrafizadeh, M., Henney, N. C., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104611 · Cited by 69
Greig, N. H., Tweedie, D., Rachmany, L., Li, Y., Rubovitch, V., Schreiber, S., Chiang, Y.-H., Hoffer, B. J., Miller, J., Lahiri, D. K., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.011 · Cited by 70
GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
Monti, G., Gomes Moreira, D., Richner, M., Mutsaers, H. A. M., Ferreira, N., & Jan, A. (2022) · Cells · doi:10.3390/cells11132023 · Cited by 68
Patharapankal, E. J., Ajiboye, A. L., Mattern, C., & Trivedi, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010066 · Cited by 82
CHILTON, R. J., Wyatt, J., Nandish, S., OLIVEROS, R. A., & Lujan, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.004 · Cited by 73
Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice
Bomba, M., Granzotto, A., Castelli, V., Massetti, N., Silvestri, E., Canzoniero, L. M. T., Cimini, A., & Sensi, S. L. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.009 · Cited by 69
Deciphering Metabolic Messages From the Gut Drives Therapeutic Innovation: The 2014 Banting Lecture
Drucker, D. J. (2015) · Diabetes · doi:10.2337/db14-1514 · Cited by 67
Self-citationBanks, W. A., Morley, J. E., Niehoff, M. L., & Mattern, C. (2009) · Journal of Drug Targeting · doi:10.1080/10611860802382777 · Cited by 68
Self-citationDelivery of peptides to the brain: Emphasis on therapeutic development
Banks, W. A. (2008) · Peptide Science · doi:10.1002/bip.20980 · Cited by 68
Self-citationMansur, R. B., Zugman, A., Ahmed, J., Cha, D. S., Subramaniapillai, M., Lee, Y. L., Lovshin, J. A., Lee, J. G., Lee, J.-H., Drobinin, V., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.08.433 · Cited by 73
Nader, M. A., Ateyya, H., El‐Shafey, M., & El-Sherbeeny, N. A. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.10.006 · Cited by 75
Yin, F., Liu, J., Zheng, X., Guo, L., & Xiao, H. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1841 · Cited by 72
Denver, P., Gault, V. A., & McClean, P. L. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13210 · Cited by 67
Cognitive and neuronal systems underlying obesity
Kanoski, S. E. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.01.007 · Cited by 66
Russell, S. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9729-9 · Cited by 77
Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases
Chen, S., Chuang, Y., Lin, T., & Yang, J. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175439 · Cited by 73
Dietary Fiber, Gut Peptides, and Adipocytokines
Sánchez‐Infantes, D., Miguel, M., & Aleixandre, A. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2011.0072 · Cited by 70
Effects of semaglutide on gut microbiota, cognitive function and inflammation in obese mice
Feng, J., Teng, Z., Yu, Y., Liu, J., & Chen, S. (2024) · PeerJ · doi:10.7717/peerj.17891 · Cited by 76
Insulin dysfunction and allostatic load in bipolar disorder
Brietzke, E., Kapczinski, F., Grassi-Oliveira, R., Grande, I., Vieta, E., & McIntyre, R. S. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.185 · Cited by 65
Bomba, M., Granzotto, A., Castelli, V., ONOFRJ, M. C., Lattanzio, R., Cimini, A., & Sensi, S. L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-190237 · Cited by 69
Protection of exendin-4 analogue in early experimental diabetic retinopathy
Zhang, Y., Wang, Q., Zhang, J., Lei, X., Xu, G.-T., & Ye, W. (2008) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-1004-3 · Cited by 68
Jantrapirom, S., Nimlamool, W., Chattipakorn, N., Chattipakorn, S., Temviriyanukul, P., Inthachat, W., Govitrapong, P., & Potikanond, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051725 · Cited by 60
Targeting Microglia to Treat Degenerative Eye Diseases
Wang, S. K., & Cepko, C. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843558 · Cited by 72
Combining GLP ‐1 receptor agonists with insulin: therapeutic rationales and clinical findings
Holst, J. J., & Vilsbøll, T. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01628.x · Cited by 63
G protein-coupled receptors as new therapeutic targets for type 2 diabetes
Reimann, F., & Gribble, F. M. (2015) · Diabetologia · doi:10.1007/s00125-015-3825-z · Cited by 70
The physiological role of the brain GLP-1 system in stress
Holt, M. K., & Trapp, S. (2016) · Cogent Biology · doi:10.1080/23312025.2016.1229086 · Cited by 63
Guerrero-Hreins, E., Goldstone, A. P., Brown, R. M., & Sumithran, P. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110303 · Cited by 62
Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
Punjabi, M., Arnold, M., Geary, N., Langhans, W., & Pacheco‐López, G. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.02.038 · Cited by 75
Bidirectional metabolic regulation of neurocognitive function
Stranahan, A. M., & Mattson, M. P. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.01.004 · Cited by 62
Hansen, H. H., Fabricius, K., Barkholt, P., Kongsbak-Wismann, P., Schlumberger, C., Jelsing, J., Terwel, D., Termont, A., Pyke, C., Knudsen, L. B., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158205 · Cited by 62
Metadata
- Authors
- During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., & Haile, C. N.
- Affiliations
- University of Auckland (NZ)
- Thomas Jefferson University (US)
- St. Louis VA Medical Center (US)
- University of Toronto (CA)
- Corresponding author
- During, Matthew J
- ORCID
- Venue
- Nature Medicine
- Published
- 2003-08-17
- Volume
- 9
- Issue
- 9
- Pages
- 1173-1179
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2124852816
- Cited by
- 851
- References
- 42
- Citations by year
- 2026: 34 · 2025: 40 · 2024: 50 · 2023: 39 · 2022: 58 · 2021: 53 · 2020: 44 · 2019: 36 · 2018: 37 · 2017: 39 · 2016: 34 · 2015: 54 · 2014: 46 · 2013: 47 · 2012: 43
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Marsden Fund
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- GLP-1 receptor, glucagon-like peptide-1, associative learning, spatial learning, memory, hippocampus, neuroprotection, kainate-induced seizures, neuronal apoptosis, cognitive enhancement, gut-brain signaling
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Administration, Intranasal, Amino Acid Sequence, Animals, Behavior, Animal, Cognition, Glucagon, Hippocampus, Kainic Acid, Learning, Male, Molecular Sequence Data, Neurons, Peptide Fragments, Protein Precursors, Seizures, Signal Transduction, Gene Expression, Rats, Sprague-Dawley, Apoptosis, Sequence Homology, Amino Acid, Gene Transfer Techniques, Receptors, Glucagon, Mice, Knockout, Neuroprotective Agents, Mice, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.